|
1
|
Pietras RJ, Márquez DC, Chen HW, et al:
Estrogen and growth factor receptor interactions in human breast
and non-small cell lung cancer cells. Steroids. 70:372–381. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stabile LP, Davis AL, Gubish CT, et al:
Human non-small cell lung tumors and cells derived from normal lung
express both estrogen receptor alpha and beta and show biological
responses to estrogen. Cancer Res. 62:2141–2150. 2002.PubMed/NCBI
|
|
3
|
Rikova K, Guo A, Zeng Q, et al: Global
survey of phosphotyrosine signaling identifies oncogenic kinases in
lung cancer. Cell. 131:1190–1203. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Orlova A, Hofström C, Strand J, et al:
[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for
visualization of insulin-like growth factor-1 receptor expression
in malignant tumours. Eur J Nucl Med Mol Imaging. 40:439–449. 2013.
View Article : Google Scholar
|
|
5
|
Nose N, Uramoto H, Iwata T, et al:
Expression of estrogen receptor beta predicts a clinical response
and longer progression-free survival after treatment with EGFR-TKI
for adenocarcinoma of the lung. Lung Cancer. 71:350–355. 2011.
View Article : Google Scholar
|
|
6
|
Torres-Arzayus MI, Zhao J, Bronson R and
Brown M: Estrogen-dependent and estrogen-independent mechanisms
contribute to AIB1-mediated tumor formation. Cancer Res.
70:4102–4111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Davydov MI, Bogush TA, Polotskiĭ BE and
Tiuliandin SA: Estrogen receptors beta - new target in cellular
lung cancer treatment. Vestn Ross Akad Med Nauk. 2:16–22. 2012.In
Russian.
|
|
8
|
Nose N, Sugio K, Oyama T, et al:
Association between estrogen receptor-beta expression and epidermal
growth factor receptor mutation in the postoperative prognosis of
adenocarcinoma of the lung. J Clin Oncol. 27:411–417. 2009.
View Article : Google Scholar
|
|
9
|
Dey P, Jonsson P, Hartman J, et al:
Estrogen receptors β1 and β2 have opposing roles in regulating
proliferation and bone metastasis genes in the prostate cancer cell
line PC3. Mol Endocrinol. 26:1991–2003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Z, Liao Y, Tang H and Chen G: The
expression of estrogen receptors β2, 5 identifies and is associated
with Prognosis in non-small cell lung cancer. Endocrine.
44:517–524. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
King AE, Collins F, Klonisch T, et al: An
additive interaction between the NFkappaB and estrogen receptor
signalling pathways in human endometrial epithelial cells. Hum
Reprod. 25:510–518. 2010. View Article : Google Scholar :
|
|
12
|
Duan R, Ginsburg E and Vonderhaar BK:
Estrogen stimulates transcription from the human prolactin distal
promoter through AP1 and estrogen responsive elements in T47D human
breast cancer cells. Mol Cell Endocrinol. 281:9–18. 2008.
View Article : Google Scholar
|
|
13
|
Airoldi I, Cocco C, Di Carlo E, et al:
Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism
for pediatric B-acute lymphoblastic leukemia cells. Cancer Res.
66:3978–3980. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Airoldi I, Di Carlo E, Banelli B, et al:
The IL-12Rbeta2 gene functions as a tumor suppressor in human B
cell malignancies. J Clin Invest. 113:1651–1659. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Airoldi I, Di Carlo E, Cocco C, et al:
IL-12 can target human lung adenocarcinoma cells and normal
bronchial epithelial cells surrounding tumor lesions. PLoS One.
4:e61192009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suzuki M, Iizasa T, Nakajima T, et al:
Aberrant methylation of IL-12Rbeta2 gene in lung adenocarcinoma
cells is associated with unfavorable prognosis. Ann Surg Oncol.
14:2636–2642. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li H, Cao MY, Lee Y, et al: Virulizin, a
novel immunotherapy agent, activates NK cells through induction of
IL-12 expression in macrophages. Cancer Immunol Immunother.
54:1115–1126. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lecocq M, Detry B, Guisset A and Pilette
C: FcαRI-mediated inhibition of IL-12 production and priming by
IFN-γ of human monocytes and dendritic cells. J Immunol.
190:2362–2371. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kontoyiannis D, Kotlyarov A, Carballo E,
et al: Interleukin-10 targets p38 MAPK to modulate ARE-dependent
TNF mRNA translation and limit intestinal pathology. EMBO J.
20:3760–3770. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fahmi A, Smart N, Punn A, et al:
P42/p44-MAPK and PI3K are sufficient for IL-6 family
cytokines/gp130 to signal to hypertrophy and survival in
cardiomyocytes in the absence of JAK/STAT activation. Cell Signal.
25:898–909. 2013. View Article : Google Scholar :
|
|
21
|
Korhonen R, Huotari N, Hömmö T, et al: The
expression of interleukin-12 is increased by MAP kinase
phosphatase-1 through a mechanism related to interferon regulatory
factor 1. Mol Immunol. 51:219–226. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu ZG, Lei YY, Li WW and Chen ZG: The
co-expression of ERβ2 and IL-12Rβ2 is better prognostic factor in
non-small-cell lung cancer progression. Med Oncol. 30:5922013.
View Article : Google Scholar
|
|
23
|
Fauconnier M, Palomo J, Bourigault ML, et
al: IL-12Rβ2 is essential for the development of experimental
cerebral malaria. J Immunol. 188:1905–1914. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu J, Zhou M, Quyang J, et al: Gambogic
acid induces mitocheondria-dependent apoptosis by modulation of
Bcl-2 and Bax in mantle cell lymphoma JeKo-1 Cells. Chin J Cancer
Res. 25:183–191. 2013.PubMed/NCBI
|
|
25
|
Pan SH, Chao YC, Hung PF, et al: The
ability of LCRMP-1 to promote cancer invasion by enhancing
filopodia formation is antagonized by CRMP-1. J Clin Invest.
121:3189–3205. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Drummond AE, Britt KL, Dyson M, et al:
Ovarian steroid receptors and their role in ovarian function. Mol
Cell Endocrinol. 191:27–33. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yager JD and Davidson NE: Estrogen
carcinogenesis in breast cancer. N Engl J Med. 354:270–282. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hua S, Kittler R and White KP: Genomic
antagonism between retinoic acid and estrogen signaling in breast
cancer. Cell. 137:1259–1271. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kondadasula SV, Roda JM, Parihar R, et al:
Colocalization of the IL-12 receptor and FcgammaRIIIa to natural
killer cell lipid rafts leads to activation of ERK and enhanced
production of interferon-gamma. Blood. 111:4173–4183. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jana M, Dasgupta S, Pal U and Pahan K:
IL-12 p40 homodimer, the so-called biologically inactive molecule,
induces nitric oxide synthase in microglia via IL-12R beta 1. Glia.
57:1553–1565. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li X, Chaudry IH and Choudhry MA: ERK and
not p38 pathway is required for IL-12 restoration of T cell IL-2
and IFN-gamma in a rodent model of alcohol intoxication and burn
injury. J Immunol. 183:3955–3962. 2009. View Article : Google Scholar : PubMed/NCBI
|
